The Structural Heart Disease Center and Valve Clinic
What is structural heart disease?
Structural heart disease – a defect in the heart’s valves or chambers – can cause symptoms that leave you with little energy to live your life. That’s why at the Heart and Vascular Institute’s (HVI’s) Structural Heart Disease Center and Valve Clinic, we approach your structural heart disease head-on through strength in collaboration. Here, world-class heart experts from Stamford Health and Columbia/NewYork-Presbyterian Hospital join forces to bring you the very latest gold-standard approaches to the evaluation and treatment of all types of structural heart disease such as aortic stenosis, mitral valve stenosis and adult congenital heart disease.
Our expert physicians offer a full spectrum of structural heart and valve procedures including coronary artery stenting, valvuloplasty for aortic valve stenosis, left atrial appendage exclusion for patients
at risk for stroke due to atrial fibrillation, and procedures to treat congenital heart conditions. Even if you were previously thought to be ineligible for surgery or otherwise untreatable, you’re assured to receive the most advanced treatments to improve your longevity and quality of life.
For your convenience, every phase of your evaluation is done right here at the Center. We provide this comprehensive care in a patient-centered environment where our highly accessible physicians, nurses and staff do their utmost to make you feel as comfortable as possible.
Why Choose Us
- We collaborate with Columbia/New York-Presbyterian Hospital to provide you with the most advanced minimally invasive treatment modalities for valve repair, even if you were previously thought to be untreatable.
- A multidisciplinary team of specialty physicians in cardiac surgery, vascular surgery, cardiac imaging, and interventional cardiology including world-renowned interventional cardiologist Antonio Colombo, MD, Attending Cardiologist at Stamford Health and a Visiting Professor of Medicine at Columbia/New York-Presbyterian Hospital, will evaluate you to determine the best course of treatment.
- We provide the latest minimally invasive techniques such as transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) for patients who are at high risk for open heart surgery. TAVR is a procedure in which the aortic valve is replaced without open surgery. One of the most common valve diseases afflicting our aging population is aortic valve stenosis, the narrowing of the aortic valve opening. If you have aortic valve stenosis and you were previously thought to be ineligible for corrective surgery due either to your advanced age, comorbidities or prior surgery, you may qualify for TAVR.
- Our new Hybrid OR enables our multidisciplinary team of heart specialists – cardiac surgeons, vascular surgeons, interventional cardiologists and radiologists- to provide diagnostic and therapeutic procedures in the same room at the same time, thereby improving our efficiency and patient outcomes. The room has leading-edge radiological imaging combined with the safety and resources of an operating room.
- Patients with heart failure and severe mitral regurgitation can be evaluated for eligibility to enter the COAPT Study, a clinical trial designed to study the safety and effectiveness of the MitraClip® in heart failure patients who have severe mitral regurgitation and are not appropriate for mitral value surgery.
We provide a full spectrum of structural heart and valve procedures including:
- Balloon aortic valvuloplasty (BAV): Minimally invasive procedure that uses a balloon catheter to widen a narrowed heart valve in order to improve blood flow.
- Closure of atrial septal defect (ASD)
- Closure of patent foramen ovale (PFO)
- Complex coronary angioplasty: Minimally invasive procedure to open a narrowed artery by inflating a small balloon inside the artery to widen the vessel and increase the blood flow to the heart.
- Coronary artery stenting: The insertion of a stent (a tube-shaped device) to keep arteries open in the treatment of coronary heart disease.
- Left main coronary angioplasty: Minimally invasive procedure to open the left main coronary artery.
- Valvuloplasty: Minimally invasive procedure to treat aortic and mitral valve stenosis (narrowing of the valves).
- Transcatheter aortic valve replacement (TAVR): An innovative minimally invasive procedure in which the aortic valve is replaced without open surgery.
- Transcatheter closure for paravalvular leak: A procedure to close a small opening between the upper and lower chambers of the heart around the outside of a heart valve.